Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer

被引：0
|
作者：
Shinjiro Mizuguchi
Nobuhiro Izumi
Takuma Tsukioka
Hiroaki Komatsu
Noritoshi Nishiyama
机构：
[1] Osaka City University Hospital,Department of Thoracic Surgery
来源：
Journal of Cardiothoracic Surgery | / 13卷
关键词：
Non-small cell lung cancer; Prognosis; Recurrence-free survival; Neutrophil-lymphocyte ratio; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer
    Mizuguchi, Shinjiro
    Izumi, Nobuhiro
    Tsukioka, Takuma
    Komatsu, Hiroaki
    Nishiyama, Noritoshi
    JOURNAL OF CARDIOTHORACIC SURGERY, 2018, 13
  • [2] Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
    Lohinai, Zoltan
    Bonanno, Laura
    Aksarin, Aleksei
    Pavan, Alberto
    Megyesfalvi, Zsolt
    Santa, Balazs
    Hollosi, Virag
    Hegedus, Balazs
    Moldvay, Judit
    Conte, PierFranco
    Ter-Ovanesov, Mikhail
    Bilan, Evgeniy
    Dome, Balazs
    Weiss, Glen J.
    PEERJ, 2019, 7
  • [3] The Association of Prechemotherapy Neutrophil-Lymphocyte Ratio With Survival in Non-Small Cell Lung Cancer Patients
    Mangla, A.
    Thekkekara, R.
    Yadav, U.
    Mohajer, R.
    Lad, T.
    Stroger, John H., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S64 - S64
  • [4] The Association of Prechemotherapy Neutrophil-Lymphocyte Ratio With Survival in Non-Small Cell Lung Cancer Patients
    Mangla, A.
    Thekkekara, R.
    Yadav, U.
    Mohajer, R.
    Lad, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S670 - S670
  • [5] AN ELEVATED NEUTROPHIL-LYMPHOCYTE RATIO PREDICTS SURVIVAL IN METASTATIC NON SMALL CELL LUNG CANCER
    Clay, T. D.
    Chua, W.
    Moore, M. M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 49 - 49
  • [6] High Pretreatment Neutrophil-Lymphocyte Ratio: A Poor Prognostic Factor for Stage III Non-Small Cell Lung Cancer Patients
    Sumbul, Ahmet T.
    Batmaci, Celal
    Ucar, Edip
    Kose, Fatih
    Sedef, Ali M.
    Yildirim, Berna
    Mertsoylu, Huseyin
    Sezer, Ahmet
    Ozyilkan, Ozgur
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S690 - S690
  • [7] Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis
    Cao, Weibo
    Yu, Haochuan
    Zhu, Shuai
    Lei, Xi
    Li, Tong
    Ren, Fan
    Zhou, Ning
    Tang, Quanying
    Zu, Lingling
    Xu, Song
    CANCER MEDICINE, 2023, 12 (06): : 7065 - 7076
  • [8] High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer
    Shao, N.
    Cai, Q.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (10): : 772 - 778
  • [9] The prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapy
    Yilmaz, Ufuk
    Ozdemir, Ozer
    Batum, Ozgur
    Ermin, Sinem
    INDIAN JOURNAL OF CANCER, 2018, 55 (03) : 276 - 281
  • [10] Association of Pre- and Posttreatment Neutrophil-Lymphocyte Ratio With Recurrence and Mortality in Locally Advanced Non-Small Cell Lung Cancer
    Sebastian, Nikhil T.
    Raj, Rohit
    Prasad, Rahul
    Barney, Christian
    Brownstein, Jeremy
    Grecula, John
    Haglund, Karl
    Xu-Welliver, Meng
    Williams, Terence M.
    Bazan, Jose G.
    FRONTIERS IN ONCOLOGY, 2020, 10
12345